Skip to main content
. 2021 Sep 1;26(17):5324. doi: 10.3390/molecules26175324

Table 4.

Growth % of NCI renal cancer cell lines treated with tested compounds (15a–l).

Compound Growth%
Renal Cancer Cell Line
A498 CAKI-1 RXF 393 TK-10 UO-31
15a 76 96 100 98 97
15b 76 93 100 84 95
15c 68 69 65 73 65
15d 23 56 37 62 53
15e 53 48 57 53 54
15f 39 45 63 59 42
15g 55 70 53 72 61
15h 41 66 48 62 57
15i 57 66 59 60 59
15j 59 41 70 56 58
15k 87 71 68 65 72
15l 56 63 82 60 75